Last $113.77 USD
Change Today -0.73 / -0.64%
Volume 114.3K
BIO On Other Exchanges
New York
New York
As of 8:04 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

bio-rad laboratories-a (BIO) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/21/14 - $134.13
52 Week Low
11/5/14 - $102.71
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO-RAD LABORATORIES-A (BIO)

Related News

No related news articles were found.

bio-rad laboratories-a (BIO) Related Businessweek News

View More BusinessWeek News

bio-rad laboratories-a (BIO) Details

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

7,750 Employees
Last Reported Date: 03/18/14
Founded in 1952

bio-rad laboratories-a (BIO) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $810.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $423.3K
Chief Operating Officer
Total Annual Compensation: $577.0K
Executive Vice President of International Sal...
Total Annual Compensation: $406.7K
Compensation as of Fiscal Year 2013.

bio-rad laboratories-a (BIO) Key Developments

Bio-Rad Laboratories, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 01:30 PM

Bio-Rad Laboratories, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 01:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Norman D. Schwartz, Chairman, Chief Executive Officer and President.

Bio-Rad Receives Premarket Application Approval for its Geenius HIV 1/2 Supplemental Assay

Bio-Rad Laboratories, Inc. announced that it has received Premarket Application approval from the U.S. Food and Drug Administration for Bio-Rad's Geenius(TM) HIV 1/2 Supplemental Assay (test). The Geenius HIV 1/2 Supplemental Assay is a single-use immunochromatographic assay intended for use as an additional, more specific, test to confirm the presence of and differentiate antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1 and HIV-2) for specimens found to be repeatedly reactive by diagnostic screening procedures. The assay may also be used to confirm the presence of antibodies to HIV-1 and/or HIV-2 in pediatric subjects (children as young as 2 years old).

Bio-Rad Laboratories Seeking Acquisitions

Bio-Rad Laboratories, Inc. (NYSE:BIO) continues to review possible acquisitions to expand both Life Science and Clinical Diagnostics segment.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIO:US $113.77 USD -0.73

BIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $40.58 USD -0.62
BioMerieux €98.10 EUR -0.09
PerkinElmer Inc $44.49 USD +0.55
QIAGEN NV €20.10 EUR -0.59
Siemens Ltd 1,056 INR -0.3501
View Industry Companies

Industry Analysis


Industry Average

Valuation BIO Industry Range
Price/Earnings 41.6x
Price/Sales 1.5x
Price/Book 1.5x
Price/Cash Flow 34.2x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-RAD LABORATORIES-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at